Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor | Patent Number 10993942

US 10993942 B2
Application Number16827650
Publication NumberUS 20200253963 A1
Pendency1 year, 1 month, 12 days
Filled DateMar 23, 2020
Priority DateSep 7, 2012
Publication DateAug 13, 2020
Expiration DateSep 6, 2032
Inventor/ApplicantsChristian Klein
Wayne John Fairbrother
Sari L. Heitner Enschede
Deepak Sampath
John F. Seymour
Andrew W. Roberts
Rod A. Humerickhouse
ExaminesXIAO, YAN
Art Unit1642
Technology Center1600
Assignments
Abbvie Inc.
Current
Genentech IncRoche
Original
Abbvie Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.